PILA PHARMA

Lista

First North

Sektor

Health Care

PILA PHARMA AB (publ) operates as a clinical stage pharmaceutical company in Sweden. It is developing XEN-D0501, a TRPV1 antagonist that has completed two phase 2b clinical trials for type 2 diabetes. The company was incorporated in 2014 and is based in Malmö, Sweden.


Ranks


Kursgraf

Länk till dynamisk (zoombar) graf för större skärmar


Nuvarande och kommande formation


MA Rank

Rulla till toppen